Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Old article, but some folks never change...
WHY DID COMMENTS CRITICAL OF THESTREET.COM AND ADAM FEUERSTEIN DISAPPEAR?
But it is an article by AF.
SP in the toilet is always a great opportunity for senior management to load up on cheap options. Heck of a job, there, Sneaky Tom.
Wonder what Sneaky Tom is up to now. Must be a doozy given the price action.
If They added, wouldn’t their aggregate increase instead of decreasing? Looks like both CVI and Kingdon are both lower than previously reported.
New 13 g/a filed. If reading correct, looks like a near 50% reduction in beneficial ownership by CVI bringing them down to 4.9% ownership. Thoughts?
Wondering what Sneaky Tom did this time.
Unfortunately, with that and some of the financing surprises, shorts have a lot of fodder to work with, and so do longs looking to accumulate cheap shares, for that matter.
Don't see the Keytruda news as bad, per se. Vicinium has the better safety profile, no?
Damned if I know, lol. Selling on the news of JP Morgan Investor Conference next week? Maybe some mischief in advance of an ATM? Let's see if there's a pump coming.
Nice momentum on volume. Hopefully price follows and there is no sell off or dilution on next news. That's a lot to ask, but wishing everyone a great 2020!
Agree, but don’t tout a “cash runway” then dilute over a weekend into a big catalyst and publish conflicting dates as to when offering closes and not respond to investor questions about same and not correct the known conflict. Deals were a little to sweet for the investment bank and connected insiders at the expense of retail, who provides the liquidity for the secondaries. Hope management negotiates better with Big Pharma. Just sayin.
And Sneaky Tom will dilute the heck out of it with an ATM. Technology is good, but too much footsie financing with mgmt and investment banks.
Sneaky Tom is definitely a piece of work.
Looking good vs the Keytruda ODAC eval. Too bad Sneaky Tom diluted us into danger of delisting and serious vulnerability to a short attack following a remedial R/S. Heck of a job, there, Sneaky.
If the dilution were "baloney," then longs would have more equity right now. Take your baloney if that makes you happy, but I'd prefer SP $$. Unfortunately, management and IR have been less than stellar on communication about and structure of add-on financing, which some find a tad annoying. Just sayin.
Sneaky Tom, The Grinch Who Stole Shareholder Equity. $0.94! What's next, an ATM announcement even through there is "sufficient cash" through Q4 2020?
And then Sneaky Tom will dilute.
Another positive catalyst, but yet the SP drops. Looks like the market is on to Sneaky Tom and his dilution games, and just expects more of the same. If we get really lucky, he'll even issue more cheap warrants to management!
Never underestimate Sneaky Tom the Dilutor. Slammed the breaks on the last catalyst to set up this swift move. Wonder how the pumpers always line up just before Old Sneaky devalues. It’s like they have a crystal ball, or something.
Sneaky Tom, liner of pockets, strikes again.
It's always the next catalyst, until Sneaky Tom figures out a way to kill the momentum and feather some connected nests at the expense of the other shareholders. Ya gotta wonder whose side he's on.
If there was a buyout offer, Sneaky Tom would sneak in a batch of discounted warrants to his special friends so they could dilute into the news.
Looks like another Sneaky Tom pump and dilute. How do the pumpers always know when to run up just before the dilution news comes? Just sayin.
As long as Sneaky Tom doesn't kill any momentum with an ATM or some other dilution, we should be good.
Or sell for 60% of the value. When it comes to facepalm decision making, never underestimate Sneaky Tom.
Sneaky Tom strikes again. Wants to dilute retail away for the benefit of his cronies.
Up she goes!
Price follows volume. Should start to move nicely from here.
Stock is undervalued and catalysts expected in Nov.
A very easy jump. And maybe a bigger spike if there is a consolidation war.
It would depend on when a deal was cut. Also need to factor in the outstanding warrants.
Merck. $8.00
Chart might attract algo traders just as we are ready for positive news catalysts.
To call this volume level anemic would be an understatement. Maybe Sneaky Tom will do another financing so his buddies can run the SP up before pushing it back down.
Of course it takes time, which is why we have nothing else to post about but the sweetheart financing deal, management taking care of itself with option awards, and Sneaky Tom taking care of his cronies. ;)
Same reason as everyone else... don’t like being dead money while management maneuvers for their own benefit. 0.65 would be a great price to pick up shares, but also gets us delisted so probably not a good trade off.
More news about more shares for management. Are we done yet? Maybe now Sneaky Tom will focus on spreading the word about the science, the data, and BLA milestones.
SP falling. Quick Tom, hire some more of your friends!